EU regulators back blood cancer stem cell therapyMolmed’s treatment aims to prevent reduce risk of graft-versus-host disease. Share XEU regulators back blood cancer stem cell therapyhttps://pharmaphorum.com/news/eu-regulators-back-blood-cancer-stem-cell-therapy/